Pharvaris (PHVS) Research & Development (2020 - 2026)
Pharvaris (PHVS) posted Research & Development of -$40.68 million for Q2 2026, compared with -$33.51 million a year earlier.
Powered by 
Analysis
Pharvaris (PHVS) Research & Development (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Pharvaris was -$150.59 million; for FY2025, it was -$140.64 million.
- In prior years, Pharvaris' Research & Development was -$106.68 million in FY2024, -$70.93 million in FY2023, -$60.47 million in FY2022 and -$42.35 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Research & Development since Q4 2020.
- According to Business Quant data, Research & Development for the three prior quarters was -$35.31 million (Q1 2026), -$39.74 million (Q4 2025) and -$34.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Pharvaris | 1.83 Bn | 451.04 Mn | - | 40.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.68 Mn |
| Mar 31, 2026 | -35.31 Mn |
| Dec 31, 2025 | 250.05 Mn |
| Sep 30, 2025 | -34.86 Mn |
| Jun 30, 2025 | 33.51 Mn |
| Mar 31, 2025 | -32.52 Mn |
| Dec 31, 2024 | 177.31 Mn |
| Sep 30, 2024 | -28.32 Mn |
| Jun 30, 2024 | 24.84 Mn |
| Mar 31, 2024 | -20.11 Mn |
| Dec 31, 2023 | 121.08 Mn |
| Sep 30, 2023 | -20.18 Mn |
| Jun 30, 2023 | 15.99 Mn |
| Mar 31, 2023 | -14.75 Mn |
| Dec 31, 2022 | 100.70 Mn |
| Sep 30, 2022 | -14.21 Mn |
| Jun 30, 2022 | 14.64 Mn |
| Mar 31, 2022 | -15.17 Mn |
| Dec 31, 2021 | 69.64 Mn |
| Sep 30, 2021 | -10.56 Mn |
API Access
Pharvaris Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();